Zinzino AB (publ) reported preliminary sales results for the month and first quarter ended March 2023. For the month, the company reported sales markets increased by 13% and amounted to SEK 135.4 (119.5) million. Faun Pharma's external sales were unchanged and amounted to SEK 9.9 (9.9) million. Overall, the Group increased revenues by 12% to SEK 145.3 (129.4) million compared with the previous year.

For the year to date, the company reported revenue for Zinzino's sales markets increased by 20% and amounted to SEK 365.3 (311.1) million. Faun Pharma's external sales increased by 19% and amounted to SEK 27.7 (23.3) million. Overall, the Group increased revenues by 21% to SEK 393.0 (334.4) million compared with the previous year.